Using Patient Outcomes to Inform Surgical Education
利用患者结果为外科教育提供信息
基本信息
- 批准号:9118829
- 负责人:
- 金额:$ 63.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdverse eventAffectAlgorithmsBlood TransfusionCaringCase MixesCessation of lifeCharacteristicsClinicalCodeCommunitiesConsultationsCredentialingDataData SetDevelopmentDiagnostic testsEducationEnrollmentEnsureEquilibriumFailureFellowshipFutureGoalsHealthHealthcareHemorrhageHospitalsHourKnowledgeMedicare claimMethodologyMethodsMonitorNatureOperative Surgical ProceduresOralOutcomePatient CarePatient EducationPatient-Focused OutcomesPatientsPatternPerformancePhasePolicy MakerPopulationPostoperative PeriodProceduresProcessProgram DevelopmentPublic HealthQuality of CareRepeat SurgeryResearchResidenciesResidual stateResourcesRisk FactorsRoleSecureSurgeonTechniquesTechnologyTestingThromboembolismTimeTrainingUnited StatesVariantVenouscohortcosteconomic outcomeenvironmental changeexperiencehealth care deliveryimprovedindividual patientmedical specialtiesnovelnovel strategiesoperationskillstrendwound
项目摘要
DESCRIPTION (provided by applicant): An estimated 10 million patients undergo an operative procedure annually in the United States. Despite overall improvements in outcomes, over 120,000 people die following surgery each year in the US. Many more will suffer from adverse events. Nascent research suggests that a significant proportion of the variation in outcomes occurs at the level of the operative surgeons. Yet, recent changes in the nature of surgical care, increased scrutiny of surgical outcomes, and duty-hour reform have dramatically changed the surgical training process. Resultant concerns regarding the quality of the modern new surgeons are substantiated by the recent sharp increase in the oral board failure rate. To date, no one has been able to examine the quality of the modern new surgeons because they have only recently entered the workforce. Using the introduction of the duty-hour reform in 2003 as a landmark for the larger set of systematic changes, we aim to understand the effects of environmental changes on the quality of care provided by new surgeons and the public health implications of changes in the surgical field on the emerging surgical workforce. In this proposal,
using a customized Medicare claims dataset including all new surgeons across 50 states, we will use a novel two-step matching process developed specifically for this study and a difference-in-difference (D-in-D) approach to examine the effects of training in the modern era on the new surgeon product. New surgeons will be classified as modern or traditional by the year in which they entered residency. Surgeon pairs will be constructed for the modern (AY 2009-2013), transitional and traditional (AY1999-2003) training eras. The first step of the "two- step" match pairs new and experienced surgeons by the surgical procedures they performed at the same hospital in the same time period. Step two matches individual patients inside each matched surgeon pair. Using this two-step matching approach, we can control for procedure, technical and patient characteristics such that the patients treated by new and experienced surgeons within hospitals will be virtually identical. The D-in-D approach using experienced surgeons as controls minimizes confounding associated with changes in the delivery of healthcare over time. Post-match regression will be used to control for residual confounders like fellowship status. Subset analysis will permit focused examination of specific clinical cohorts to provide transparently meaningful results. Moreover, we will derive time to proficiency curves across multiple specialties and within specific clinical cohorts. Aim 1 will examine clinical outcomes and Aim 2, economic outcomes. After completing the project, we will be able to 1) inform the ACGME and ABMS on gaps in new surgeon performance for subsequent education reform, 2) use the methodology developed for this proposal to monitor any future reform and 3) advise CMS (and other payors) and surgeons on strategies for focused professional development programs (e.g., surgical coaching or phased privileging or credentialing) to improve the quality of care delivered to surgical patients today and safeguard the care of surgical patients in the future.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rachel Kelz其他文献
Rachel Kelz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rachel Kelz', 18)}}的其他基金
Personalized Provider Selection to Reduce Surgical Disparities
个性化的医疗服务提供者选择以减少手术差异
- 批准号:
10624968 - 财政年份:2022
- 资助金额:
$ 63.49万 - 项目类别:
Personalized Provider Selection to Reduce Surgical Disparities
个性化的医疗服务提供者选择以减少手术差异
- 批准号:
10445916 - 财政年份:2022
- 资助金额:
$ 63.49万 - 项目类别:
Using Outcomes to Guide Treatment of Surgical Emergencies
利用结果指导外科紧急情况的治疗
- 批准号:
10152509 - 财政年份:2019
- 资助金额:
$ 63.49万 - 项目类别:
Using Outcomes to Guide Treatment of Surgical Emergencies
利用结果指导外科紧急情况的治疗
- 批准号:
10402798 - 财政年份:2019
- 资助金额:
$ 63.49万 - 项目类别:
Using Outcomes to Guide Treatment of Surgical Emergencies
利用结果指导外科紧急情况的治疗
- 批准号:
10667738 - 财政年份:2019
- 资助金额:
$ 63.49万 - 项目类别:
Using Outcomes to Guide Treatment of Surgical Emergencies
利用结果指导外科紧急情况的治疗
- 批准号:
10370161 - 财政年份:2019
- 资助金额:
$ 63.49万 - 项目类别:
Using Outcomes to Guide Treatment of Surgical Emergencies
利用结果指导外科紧急情况的治疗
- 批准号:
10619027 - 财政年份:2019
- 资助金额:
$ 63.49万 - 项目类别:
Using Outcomes to Guide Treatment of Surgical Emergencies
利用结果指导外科紧急情况的治疗
- 批准号:
10828099 - 财政年份:2019
- 资助金额:
$ 63.49万 - 项目类别:
Using Patient Outcomes to Inform Surgical Education
利用患者结果为外科教育提供信息
- 批准号:
9308803 - 财政年份:2015
- 资助金额:
$ 63.49万 - 项目类别:
Using Patient Outcomes to Inform Surgical Education
利用患者结果为外科教育提供信息
- 批准号:
8985515 - 财政年份:2015
- 资助金额:
$ 63.49万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 63.49万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 63.49万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 63.49万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 63.49万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 63.49万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 63.49万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 63.49万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 63.49万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 63.49万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 63.49万 - 项目类别:














{{item.name}}会员




